TRILLIUM THERAPEUTICS INC. Financing Cash Flow
TRILLIUM THERAPEUTICS INC. reported Financing Cash Flow of $2.64 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2021-09-30 was $112.00K, a 99.93% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was $895.00K, a 51.17% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was $1.63M, a 98.64% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $3.50M.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2020 was $290.91M, a 2006.50% increase from fiscal 2019.
- TRILLIUM THERAPEUTICS INC. net cash provided by (used in) financing activities for fiscal 2019 was $13.81M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.01M derived: sum of 2 quarters · filed 2021-11-12 | $2.64M 10-Q · filed 2021-11-12 | $6.14M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $895.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $2.53M 10-Q · filed 2021-08-13 | $6.03M derived: sum of 3 quarters · filed 2021-08-13 | $171.72M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $1.63M 10-Q · filed 2021-05-07 | $5.13M derived: sum of 2 quarters · filed 2021-05-07 | $170.83M derived: sum of 3 quarters · filed 2021-11-12 | $172.66M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $169.20M derived: sum of 2 quarters · filed 2021-11-12 | $171.03M derived: sum of 3 quarters · filed 2021-11-12 | $290.91M 10-K · filed 2021-03-18 |
| 2020-09-30 | $165.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $167.53M derived: sum of 2 quarters · filed 2021-11-12 | $287.40M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $121.71M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $119.88M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $13.81M 10-K · filed 2021-03-18 |